Masashi Shimoda

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Combination Therapy

Body Composition

Positive Breast Cancer

Glycemic Control

Top Venues

Journal of diabetes investigation

Diabetes, obesity & metabolism

Journal of diabetes research

Diabetes therapy : research, treatment and education of diabetes and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism 26 (6) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Masashi Shimoda, Yuichi Morimoto, Yuki Watanabe, Takashi Itoh, Taku Sasaki, Shigehito Mori, Masato Kubo, Haruka Takenouchi, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes. Diabetes, obesity & metabolism 26 (7) (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Masashi Shimoda, Yuichi Morimoto, Yuki Watanabe, Takashi Itoh, Taku Sasaki, Shigehito Mori, Masato Kubo, Haruka Takenouchi, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes. Diabetes, obesity & metabolism (2024)
Hideyuki Iwamoto, Tomohiko Kimura, Yoshiro Fushimi, Masahiro Iwamoto, Fuminori Tatsumi, Junpei Sanada, Yuichiro Iwamoto, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching. Diabetes, obesity & metabolism (2024)
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Yuka Nogami, Yoshiko Shirakiya, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Diabetes, obesity & metabolism 26 (6) (2024)
Shuhei Nakanishi, Masashi Shimoda, Tomohiko Kimura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation 15 (7) (2024)
Tomohiko Kimura, Yukino Katakura, Masashi Shimoda, Fumiko Kawasaki, Mizuho Yamabe, Fuminori Tatsumi, Michihiro Matsuki, Yuichiro Iwamoto, Takatoshi Anno, Yoshiro Fushimi, Shinji Kamei, Yukiko Kimura, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto, null null
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study). Diabetes, obesity & metabolism (2023)
Shuhei Nakanishi, Masashi Shimoda, Fuminori Tatsumi, Kenji Kohara, Atsushi Obata, Yukino Katakura, Junpei Sanada, Yoshiro Fushimi, Yuichiro Iwamoto, Mana Onishi, Hayato Isobe, Takashi Kusano, Kazunori Dan, Ryo Wamata, Hideyuki Iwamoto, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Effects of sedentary behavior and daily walking steps on body mass index and body composition: Prospective observational study using outpatient clinical data of Japanese patients with type 2 diabetes. Journal of diabetes investigation 12 (9) (2021)
Shuhei Nakanishi, Masashi Shimoda, Fuminori Tatsumi, Kenji Kohara, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Association between Grit Scales and adherence to regular hospital visits among Japanese patients with type 2 diabetes: Prospective observational study. Journal of diabetes investigation (2021)
Hayato Isobe, Masashi Shimoda, Yuki Kan, Fuminori Tatsumi, Yukino Katakura, Tomohiko Kimura, Atsushi Obata, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time. BMC endocrine disorders 21 (1) (2021)
Yuichiro Iwamoto, Fuminori Tatsumi, Hayato Isobe, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Hideaki Kaneto
Acute and extremely severe necrotic esophagitis accompanied by hyperglycemic hyperosmolar syndrome in a subject with type 2 diabetes mellitus. Journal of diabetes investigation 12 (10) (2021)
Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima, Yoshiro Fushimi, Yurie Hirata, Akihito Tanabe, Fuminori Tatsumi, Hidenori Hirukawa, Junpei Sanada, Kenji Kohara, Shintaro Irie, Tomohiko Kimura, Yoshiko Nakamura, Momoyo Nishioka, Atsushi Obata, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. Journal of diabetes investigation 11 (6) (2020)
Yoshiro Fushimi, Atsushi Obata, Junpei Sanada, Yuichiro Iwamoto, Akiko Mashiko, Megumi Horiya, Akiko Mizoguchi-Tomita, Momoyo Nishioka, Yuki Kan, Tomoe Kinoshita, Seizo Okauchi, Hidenori Hirukawa, Kenji Kohara, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study. Journal of diabetes research 2020 (2020)
Tomoe Kinoshita, Masashi Shimoda, Junpei Sanada, Yoshiro Fushimi, Yurie Hirata, Shintaro Irie, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Kenji Kohara, Fuminori Tatsumi, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (4) (2018)
Hidenori Hirukawa, Shinji Kamei, Tomohiko Kimura, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study. Journal of diabetes research 2018 (2018)
Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus. Journal of diabetes research 2018 (2018)
Masashi Shimoda, Maiko Miyoshi-Takai, Shintaro Irie, Akihito Tanabe, Atsushi Obata, Seizo Okauchi, Hidenori Hirukawa, Tomohiko Kimura, Kenji Kohara, Shinji Kamei, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus. Journal of diabetes research 2017 (2017)